Abeona Therapeutics (ABEO) Change in Inventory (2011 - 2026)

Abeona Therapeutics' (ABEO) quarterly Change in Inventory came in at $561000.0 in Q1 2026, down 12.75% quarter-over-quarter from $643000.0 in Q4 2025.

Abeona Therapeutics (ABEO) Change in Inventory (2011 - 2026) Analysis & Trends

Abeona Therapeutics' Change in Inventory history runs 5 years deep, the most recent figure standing at $561000.0 for Q1 2026.

  • On a quarterly basis, Change in Inventory changed N/A year-over-year to $561000.0 in Q1 2026; TTM through Mar 2026 was $3.4 million, a N/A change from a year earlier, with the FY2025 full-year figure at $5.5 million, changed N/A from the prior year.
  • Change in Inventory retreated to $561000.0 in Q1 2026 per ABEO's latest filing, from $643000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $2.2 million in Q3 2025 and bottomed at $561000.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 71.84 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 97.70 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -26.60 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Abeona Therapeutics 107.85 Mn -60.42 Mn 6.02 Mn 561,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 561,000.00
Mar 31, 2026 561,000.00
Dec 31, 2025 643,000.00
Dec 31, 2025 643,000.00
Sep 30, 2025 2.16 Mn
Sep 30, 2025 2.16 Mn
Jun 30, 2013 -150,000.00
Jun 30, 2013 -150,000.00
Mar 31, 2013 -44,000.00
Mar 31, 2013 -44,000.00
Dec 31, 2012 -42,000.00
Dec 31, 2012 -42,000.00
Sep 30, 2012 -45,000.00
Sep 30, 2012 -45,000.00
Jun 30, 2012 184,000.00
Jun 30, 2012 184,000.00
Mar 31, 2012 -54,000.00
Mar 31, 2012 -54,000.00
Dec 31, 2011 -41,000.00
Dec 31, 2011 -41,000.00